
Why Viking Therapeutics is Attracting Attention Despite Financial Turmoil
Viking Therapeutics’ stock soared over 10% despite rising financial challenges, closing at £32.29. The surge was driven by optimism for VK2735, a potential breakthrough weight loss drug. The company exemplifies entrepreneurial resilience amid market volatility, drawing investor interest. Target price adjustments by